Accelerating
Drug Discovery
Most new drugs fail before they reach patients. Our vision is to revolutionize drug discovery with Kvantify's cutting-edge, physics-based platform. Available today the platform is designed to improve efficiency, reduce risks & time-to-market, and drive meaningful progress in developing new therapies - ultimately for the benefit of patients.
Design better candidates, faster
We focus on Hit-ID to Lead Optimization, enabling customers to move from thousands to a handful of very high-quality compounds. Right now, most simulations are too slow to be done at scale early in the hit ID-process. Through our new algorithms and tools, we make calculations faster and more accurate – all while relying on the underlying physics.
Technological approach
Our approach is grounded in physics-based modeling, with AI integration where beneficial, but always anchored in physical principles. We prepare for the future of quantum computing by re-engineering classical algorithms and developing the future quantum algorithms that will add further precision computational drug discovery.
Collaborative research partnerships
We can work with your pipeline projects to generate data with our proprietary tools and cutting-edge methods. Our computational chemistry team will help you translate the data into actionable insights and guide the compound selection.
- We share insights based on our experience
- We help you interpret outputs from the tools we use
- We make recommendations to help your decision making
Some of the methods we currently offer.
Introducing: Kvantify koffee
Our ground-breaking method for unbinding kinetics enables pharma and biotech companies to iterate smarter, save time & money and derisk the drug discovery process
See how we helped Tetra Pharm Technologies choose a handful of high-quality compounds.
